glp 1 mash approval CDSCO Clears Wegovy for — India's First GLP-1 for Liver Disease, India's drug regulator CDSCO approved Novo Nordisk's Wegovy (semaglutide 2.4mg) on 17 July 2026 for MASH, based on MASH therapy enters a more
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15








.png)











00261-2/asset/f53e62a5-26b2-49b9-a677-7f10f1f91530/main.assets/gr1_lrg.jpg)






